Arteris CEO-linked entity sells 181,338 shares
Arteris, Inc. director and CEO K. Charles Janac reported indirect open-market sales of 181,338 shares of Arteris common stock on July 1, 2026 through Bayview Legacy, LLC, where he serves as manager.
Rhea-AI Filing Summary
Arteris, Inc. director and CEO K. Charles Janac reported indirect open-market sales of 181,338 shares of Arteris common stock on July 1, 2026 through Bayview Legacy, LLC, where he serves as manager. The sales were made under a Rule 10b5-1 trading plan adopted on December 12, 2025, at weighted-average prices reported between $44.0606 and $47.0752 per share.
Following these transactions, Bayview Legacy, LLC beneficially owned 8,747,733 shares of Arteris common stock indirectly attributed to Janac. Separate holding entries show an additional 196,729 shares held directly and 56,252 shares held through the Charles and Lydia Janac Trust.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 27,691 | $45.0395 | $1.25M |
| Sale | Common Stock | 63,562 | $44.0606 | $2.80M |
| Sale | Common Stock | 49,680 | $46.1653 | $2.29M |
| Sale | Common Stock | 40,405 | $47.0752 | $1.90M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (7)
- F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.68 to $45.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.
- F4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.68 to $44.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.68 to $46.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.68 to $47.63 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.
Key Figures
Key Terms
Rule 10b5-1 trading plan financial
weighted average sale price financial
beneficially owned financial
open-market sale financial
indirect ownership financial
FAQ
What did Arteris (AIP) CEO K. Charles Janac report in this Form 4?
What are K. Charles Janac’s additional Arteris (AIP) holdings outside Bayview Legacy, LLC?
How many total insider transactions are summarized in this Arteris (AIP) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.